MAPT and Alzheimer disease: In brief, in vitro studies have shown that CBD acts against Aβ-induced toxicity in various ways, including inhibition of tau hyperphosphorylation (Esposito et al., 2006a) which was associated with a reduction in the phosphorylated glycogen synthase kinase 3-β, the protein responsible for NFT formation in AD.